Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-22T14:03:00.514Z Has data issue: false hasContentIssue false

Genetic polymorphism and drug-induced movement disorders

Published online by Cambridge University Press:  03 January 2018

G. D. I. Bates
Affiliation:
Birmingham Children's Hospital, Lady wood Middleway, Lady wood, Birmingham BI68ET
A. E. van Woerkom
Affiliation:
Queen Elizabeth Psychiatric Hospital, Mindelsohn Way, Birmingham BI5 2TZ
O. Lopes
Affiliation:
Queen Elizabeth Psychiatric Hospital, Mindelsohn Way, Birmingham BI5 2TZ
R. Waring
Affiliation:
Department of Biochemistry, University of Birmingham, Edgbaston, Birmingham
L. Klovrza
Affiliation:
Department of Biochemistry, University of Birmingham, Edgbaston, Birmingham
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Copyright
Copyright © 1997 The Royal College of Psychiatrists 

References

Armstrong, M., Daly, A. K., Blennerhassett, R., et al (1997) Antipsychotic drug-induced movement disorders in schizophrenics in relation to CYP2D6 genotype. British Journal of Psychiatry, 170, 2326.Google Scholar
Bates, G. D. L. (1997) Using Promathazine to Demonstrate Abnormalities of Phenothiazine Metabolism in Tardive Dyskinesia. MMedSc dissertation, Department of Psychiatry, University of Birmingham.Google Scholar
Yasavage, J. A., Tanke, E. D. & Sheikh, J. I. (1987) Tardive dyskinesia and steady-state serum levels of thiothixene. Archives of General Psychiatry. 44, 913915.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.